Loss of human leukocyte antigen expression on colorectal tumor cell lines: implications for anti-tumor immunity and immunotherapy

J Immunother Emphasis Tumor Immunol. 1993 Oct;14(3):163-8. doi: 10.1097/00002371-199310000-00001.

Abstract

A system devised for tissue typing the human leukocyte antigen-A (HLA-A) locus from genomic DNA by the polymerase chain reaction (PCR) has been used to investigate abnormalities of HLA expression in a panel of 30 cell lines derived from colorectal adenocarcinomas, by comparison of the HLA-A locus genotype with surface expression of HLA. Eleven cell lines gave single HLA-A locus specificity on PCR typing, suggesting that loss of HLA alleles is a common abnormality. In one of these cell lines the loss of an HLA-A locus allele was confirmed by comparison with DNA from a lymphoblastoid B cell line derived from the same patient. In three cell lines, loss of expression of an HLA-A locus determinant was observed in spite of the presence of the relevant allele in genomic DNA. Three cell lines showed absent HLA expression associated with failure to express beta 2-microglobulin. These data indicate that at least three independent mechanisms were involved in the loss of HLA expression on the colorectal tumor cell lines.

MeSH terms

  • Antigens, Surface / analysis
  • Chromosome Mapping
  • Colorectal Neoplasms / immunology*
  • Colorectal Neoplasms / pathology
  • Cytotoxicity, Immunologic*
  • Genome
  • Genotype
  • HLA Antigens / analysis*
  • HLA-A Antigens / genetics
  • HLA-A2 Antigen / analysis
  • Histocompatibility Antigens Class I / analysis
  • Humans
  • Immunotherapy*
  • Polymerase Chain Reaction
  • Tumor Cells, Cultured

Substances

  • Antigens, Surface
  • HLA Antigens
  • HLA-A Antigens
  • HLA-A2 Antigen
  • Histocompatibility Antigens Class I